Oncology Launch Curve Forecaster dashboard Executive Brief showing key metrics: 10 analogs selected, $4.3B base case peak (P50) with range $2.4B-$5.2B, $244M revenue at risk (Year 1) under 2-quarter delay scenario, 20 quarters to peak. Shows start of Launch Trajectory Scenarios section.
Built an oncology launch curve forecaster. The insight? Stop asking "what will happen" and start asking "what does this assumption cost if we're wrong?"
.
🔗 tinyurl.com/5cx9s4ye
.
#rstats | #shiny | #pharma | #commercialanalytics | #decisionscience
3
1
0
0
